BRWA
CBAY

B. Riley Wealth Advisors’s Cymabay Therapeutics CBAY Stock Holding History

B. Riley Wealth Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,275
Closed -$16K – 911
2020
Q1 		$16K Sell
10,275
-5,550
-35% -$9.32K ﹤0.01% 779
2019
Q4 		$32K Sell
15,825
-8,100
-34% -$30.4K ﹤0.01% 822
2019
Q3 		$123K Buy
23,925
+1,000
+4% +$6.05K 0.01% 760
2019
Q2 		$165K Buy
+22,925
New +$260K 0.02% 731

Other funds holding CBAY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return